Cargando…
Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: an opportunity for an in vitro drug screening assay
Inflammatory bowel disease (IBD) is a widespread disease, affecting a growing demographic. The treatment of chronic inflammation located in the GI-tract is dependent on the severity; therefore, the IBD treatment pyramid is commonly applied. Animal experimentation plays a key role for novel IBD drug...
Autores principales: | Schnur, Sabrina, Wahl, Vanessa, Metz, Julia K., Gillmann, Jessica, Hans, Fabian, Rotermund, Katharina, Zäh, Ralf-Kilian, Brück, Dietmar A., Schneider, Marc, Hittinger, Marius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630817/ https://www.ncbi.nlm.nih.gov/pubmed/37520160 http://dx.doi.org/10.1007/s44164-022-00035-8 |
Ejemplares similares
-
The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease
por: Schnur, Sabrina, et al.
Publicado: (2023) -
In vitro tools for orally inhaled drug products—state of the art for their application in pharmaceutical research and industry and regulatory challenges
por: Metz, Julia Katharina, et al.
Publicado: (2021) -
Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017) -
Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection
por: Kunkel, M., et al.
Publicado: (2023) -
Proteomics study of silver nanoparticles on Caco-2 cells
por: Gioria, Sabrina, et al.
Publicado: (2018)